Table 1 Demographic, clinical and outcome parameters in the studies patients (n = 60)
From: HCV co-infection is related to acute ischemic severity and outcome
All patients N = 60 | HCV + ve n = 13 | HCV-ve n = 47 | p value | |
|---|---|---|---|---|
Age | 55.8 ± 16.1 | 52.2 ± 18.9 | 56.8 ± 15.4 | 0.37 |
Male/female | 42/18 | 7/6 | 35/12 | 0.45 |
Risk factors n (%) | ||||
Hypertension | 24 (40.0) | 5 (38.5) | 19 (40.04) | 0.9 |
Diabetes | 22 (36.7) | 7 (53.9) | 15 (31.9) | 0.15 |
Heart disease | 13 (21.7) | 4 (30.8) | 9 (19.2) | 0.37 |
Smoking | 21 (35.0) | 3 (23.1) | 18 (38.3) | 0.31 |
Dyslipidemia | 10 (16.7) | 4 (30.8) | 12 (25.5) | 0.71 |
Family history of stroke | 6 (10.0) | 2 (15.4) | 4 (8.5) | 0.6 |
Stroke subtype | ||||
Large artery disease | 25 (41.7) | 5 (38.5) | 20 (42.7) | 0.62 |
Small artery disease | 15 (25.0) | 3 (23.1) | 12 (25.5) | |
Cardio-embolic stroke | 20 (33.3) | 5 (38.5) | 15 (31.9) | |
Carotid artery state n (%) | ||||
Normal | 45 (75.0) | 4 (30.8) | 41 (87.2) | < 0.001 |
Stenosis < 50% | 11 (18.3) | 6 (46.1) | 5 (10.6) | |
Stenosis ≥50% | 4 (6.7) | 3 (23.1) | 1 (2.1) | |
NIHSS | 11.6 ± 6.5 | 17.9 ± 6.9 | 9.9 ± 5.3 | < 0.001 |
Stroke severity n (%) | ||||
Minor | 7 (11.7) | – | 7 (14.9) | 0.001 |
Moderate | 38 (63.3) | 5 (38.5) | 33 (70.2) | |
Moderate-to-severe | 7 (11.7) | 2 (15.4) | 5 (10.6) | |
Severe | 8 (13.3) | 6 (46.1) | 2 (4.3) | |
MRS | 2.5 ± 1.4 | 3.6 ± 1.3 | 2.1 ± 1.3 | 0.001 |
Outcome n (%) | ||||
Favorable | 33 (55.0) | 3 (23.1) | 30 (63.8) | 0.005 |
Unfavorable | 27 (45.0) | 10 (76.9) | 17 (36.2) | |